{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:55Z","timestamp":1783606975115,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDP\/04138\/2020"],"award-info":[{"award-number":["UIDP\/04138\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["CEECINST\/00145\/2018"],"award-info":[{"award-number":["CEECINST\/00145\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDB\/04138\/2020"],"award-info":[{"award-number":["UIDB\/04138\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["PTDC\/MEC-DER\/30198\/2017"],"award-info":[{"award-number":["PTDC\/MEC-DER\/30198\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["EXPL\/QUI-OUT\/1288\/2021"],"award-info":[{"award-number":["EXPL\/QUI-OUT\/1288\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["CEECIND\/03143\/2017"],"award-info":[{"award-number":["CEECIND\/03143\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejps.2025.107013","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T02:36:29Z","timestamp":1736735789000},"page":"107013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Combining in vitro, in vivo, and in silico approaches to evaluate the effect of serotonergic-based topical therapies on mild to moderate psoriasis"],"prefix":"10.1016","volume":"206","author":[{"given":"Ana M.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia A.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-5622","authenticated-orcid":false,"given":"Joana","family":"Marto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107013_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: keratinocytes or immune cells \u2013 which is the trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"key":"10.1016\/j.ejps.2025.107013_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2025.107013_bib0003","doi-asserted-by":"crossref","first-page":"e56427","DOI":"10.7554\/eLife.56427","article-title":"Chemical and structural investigation of the paroxetine-human serotonin transporter complex","volume":"9","author":"Coleman","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.ejps.2025.107013_bib0004","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-3083.2012.04690.x","article-title":"Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study","volume":"28","author":"D'Erme","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejps.2025.107013_bib0005","doi-asserted-by":"crossref","unstructured":"Eberle, F.C., Br\u00fcck, J., Holstein, J., Hirahara, K., Ghoreschi, K., 2016. Recent Advances in Understanding Psoriasis. F1000Research 5, F1000 Faculty Rev-1770. 10.12688\/f1000research.7927.1.","DOI":"10.12688\/f1000research.7927.1"},{"key":"10.1016\/j.ejps.2025.107013_bib0006","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1007996124545","article-title":"Empirical scoring functions: i The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes","volume":"11","author":"Eldridge","year":"1997","journal-title":"J. Comput. aided Mol. Des."},{"key":"10.1016\/j.ejps.2025.107013_bib0007","series-title":"Hyperkeratosis","author":"Farci","year":"2022"},{"key":"10.1016\/j.ejps.2025.107013_bib0008","series-title":"Plaques, Flares, and Goose oil: Psoriasis through the Ages","author":"Fasanella","year":"2020"},{"key":"10.1016\/j.ejps.2025.107013_bib0009","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pnpbp.2017.03.016","article-title":"The anti-inflammatory mechanism of antidepressants - SSRIs, SNRIs","volume":"80","author":"Galecki","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.ejps.2025.107013_bib0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/106002809202600215","article-title":"Fluoxetine-induced psoriasis","volume":"26","author":"Hemlock","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2025.107013_bib0011","first-page":"6","article-title":"Update on the pathophysiology of psoriasis","volume":"102","author":"Hugh","year":"2018","journal-title":"Cutis"},{"key":"10.1016\/j.ejps.2025.107013_bib0012","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-4632.2004.02195.x","article-title":"Immunohistochemical study of serotonin in lesions of psoriasis","volume":"43","author":"Huang","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejps.2025.107013_bib0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","article-title":"Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation","volume":"245","author":"Jones","year":"1995","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejps.2025.107013_bib0014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","article-title":"Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine","volume":"26","author":"Kimura","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejps.2025.107013_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein-ligand docking with plants","volume":"49","author":"Korb","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2025.107013_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2017.07.014","article-title":"Novel insights into the pathogenesis of psoriasis","volume":"186","author":"Luger","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejps.2025.107013_bib0017","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jim.2016.01.012","article-title":"The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus","volume":"430","author":"Lund","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejps.2025.107013_bib0018","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/cells9040796","article-title":"The brain-skin connection and the pathogenesis of psoriasis: a review with a focus on the serotonergic system","volume":"9","author":"Martins","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2025.107013_bib0019","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s12035-020-01889-3","article-title":"Current and future therapies for psoriasis with a focus on serotonergic drugs","volume":"57","author":"Martins","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejps.2025.107013_bib0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s12035-014-9068-z","article-title":"Prevention of photocarcinogenesis by agonists of 5-HT1A and antagonists of 5-HT2A receptors","volume":"53","author":"Menezes","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejps.2025.107013_bib0021","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/prot.20588","article-title":"General and targeted statistical potentials for protein-ligand interactions","volume":"61","author":"Mooij","year":"2005","journal-title":"Prot. Struct. Funct. Genet."},{"key":"10.1016\/j.ejps.2025.107013_bib0022","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(98)00028-3","article-title":"A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity","volume":"213","author":"Nociari","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejps.2025.107013_bib0023","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0625.2007.00670.x","article-title":"The skin as a mirror of the soul: exploring the possible roles of serotonin","volume":"17","author":"Nordlind","year":"2008","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejps.2025.107013_bib0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-006-0652-6","article-title":"Expression of serotonergic receptors in psoriatic skin","volume":"298","author":"Nordlind","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ejps.2025.107013_bib0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/pharmaceutics12040358","article-title":"Novel and modified neutrophil elastase inhibitor loaded in topical formulations for psoriasis management","volume":"12","author":"Nunes","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107013_bib0026","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1176\/appi.ajp.159.12.2113","article-title":"Paroxetine-associated psoriasis","volume":"159","author":"Osborne","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejps.2025.107013_bib0027","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.colsurfb.2018.01.053","article-title":"Development of nanoparticles from natural lipids for topical delivery of thymol: investigation of its anti-inflammatory properties","volume":"164","author":"Pivetta","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2025.107013_bib0028","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1038\/s41467-021-25363-3","article-title":"The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter","volume":"12","author":"Plenge","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2025.107013_bib0029","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107013_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09546630802449096","article-title":"Flare-up of pustular psoriasis with fluoxetine: possibility of a serotoninergic influence?","volume":"20","author":"Tamer","year":"2009","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.ejps.2025.107013_bib0031","doi-asserted-by":"crossref","first-page":"446e9","DOI":"10.1016\/j.genhosppsych.2009.08.008","article-title":"Onset of psoriasis during therapy with fluoxetine","volume":"32","author":"Tan Pei Lin","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.ejps.2025.107013_bib0032","series-title":"Serotonergic Mechanisms in Psoriasis","author":"Thorslund","year":"2012"},{"key":"10.1016\/j.ejps.2025.107013_bib0033","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00403-009-0933-y","article-title":"The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis","volume":"301","author":"Thorslund","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ejps.2025.107013_bib0034","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1358\/dnp.2007.20.8.1157614","article-title":"Serotonergic drugs\u2013a possible role in the treatment of psoriasis?","volume":"20","author":"Thorslund","year":"2007","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ejps.2025.107013_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/joim.12093","article-title":"Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: a population-based cohort study","volume":"274","author":"Thorslund","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejps.2025.107013_bib0036","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.pnpbp.2006.01.029","article-title":"Cytokines and serotonin transporter in patients with major depression","volume":"30","author":"Tsao","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejps.2025.107013_bib0037","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2025.107013_bib0038","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","article-title":"Structural insights into the lipid and ligand regulation of serotonin receptors","volume":"592","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2025.107013_bib0039","first-page":"Ec05","article-title":"Immunohistochemical evaluation of role of serotonin in pathogenesis of psoriasis","volume":"10","author":"Younes","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejps.2025.107013_bib0040","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41467-021-21016-7","article-title":"Asymmetric opening of the homopentameric 5-HT3A serotonin receptor in lipid bilayers","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:57:22Z","timestamp":1778558242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":40,"alternative-id":["S0928098725000120"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107013","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining in vitro, in vivo, and in silico approaches to evaluate the effect of serotonergic-based topical therapies on mild to moderate psoriasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107013"}}